NOVOCURE LTD shareholders Q3 2023

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Swiss National Bank 221,600$3,578,8400.00%
LMR Partners LLP 13,796$222,8050.00%
XPONANCE, INC. 14,375$232,1560.00%
Handelsbanken Fonder AB 34,646$5600.00%
Covestor Ltd 237$40.00%
Bridgewater Associates 27,128$438,1170.00%
GEODE CAPITAL MANAGEMENT, LLC 1,504,991$24,309,6770.00%
AMALGAMATED BANK 23,847$3850.00%
HAP Trading, LLC 40,600$19,7930.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 541,265$8,741,4300.00%
INTECH INVESTMENT MANAGEMENT LLC 12,614$203,7160.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 112,579$1,818,1510.00%
TWO SIGMA SECURITIES, LLC 19,641$317,2020.00%
BALYASNY ASSET MANAGEMENT L.P. 83,500$1,348,5250.00%
JANE STREET GROUP, LLC 545,091$8,803,2200.00%
FEDERATED HERMES, INC. 67,940$1,097,2310.00%
Citadel Advisors 671,011$10,836,8280.00%
Trifecta Capital Advisors, LLC 320$5,1680.00%
KBC Group NV 10,758$4460.00%
TWO SIGMA SECURITIES, LLC 12,300$198,6450.00%
External links

This page lists NOVOCURE LTD's shareholders in Q3 2023. To view NOVOCURE LTD's shareholder history, click here.